Skip to content
  • Topics
    • Obesity/Cancer FAQs
    • General News
    • Gastroparesis
    • Learn about Lipids
      • Obese vs Non-Obese
    • Obesity Drugs
      • Semaglutide
      • Tirzepatide
      • Obesity Drugs in the Pipeline
    • Lawsuits
    • Bariatric Surgery
    • Grants
    • Addiction
    • Journals/References/Books
    • Clinical Trials
      • Clinical Trials – United States
      • Clincal Trials – ExUS
      • Breast Cancer-Obesity Clinical Trials
    • FDA
    • Conferences
      • Conference Updates
    • Institutions
  • Blog Posts / News
    • Login
    • News Archive
    • Posts Archive
    • Guest Post
    • Author’s Registration Page
    • Author’s Post Page
    • Bloggers
  • Related Cancers
    • Breast
    • Colon & Rectum
    • Kidney
    • Endometrium
    • Pancreas
    • Thyroid
    • Liver
    • Multiple Myeloma
    • Upper Stomach
    • Meningioma
    • Adenocarcinoma of the Esophagus
    • Ovary
    • Gallbladder
    • Pediatric
    • Mesothelioma
  • About
  • Contact
  • Topics
    • Obesity/Cancer FAQs
    • General News
    • Gastroparesis
    • Learn about Lipids
      • Obese vs Non-Obese
    • Obesity Drugs
      • Semaglutide
      • Tirzepatide
      • Obesity Drugs in the Pipeline
    • Lawsuits
    • Bariatric Surgery
    • Grants
    • Addiction
    • Journals/References/Books
    • Clinical Trials
      • Clinical Trials – United States
      • Clincal Trials – ExUS
      • Breast Cancer-Obesity Clinical Trials
    • FDA
    • Conferences
      • Conference Updates
    • Institutions
  • Blog Posts / News
    • Login
    • News Archive
    • Posts Archive
    • Guest Post
    • Author’s Registration Page
    • Author’s Post Page
    • Bloggers
  • Related Cancers
    • Breast
    • Colon & Rectum
    • Kidney
    • Endometrium
    • Pancreas
    • Thyroid
    • Liver
    • Multiple Myeloma
    • Upper Stomach
    • Meningioma
    • Adenocarcinoma of the Esophagus
    • Ovary
    • Gallbladder
    • Pediatric
    • Mesothelioma
  • About
  • Contact

Uncategorized

Demand for weight loss drugs is growing. Can wellness companies keep up?

April 17, 2025April 16, 2025 by Condie Carmack

Wellness startups are launching products that target the natural growth of GLP-1, the hormone that medicines like Ozempic and Mounjaro mimic. Experts warn that the traditional wellness industry must adapt to remain relevant in the market

Categories Uncategorized Tags Apr 17 Leave a comment
Newer posts
← Previous Page1 … Page35 Page36
Facebook Twitter
© Copyright 2025 GenWeb of Texas